Skip to main content

Advertisement

SpringerLink
Log in

Primary versus secondary antiphospholipid syndrome: Is this lupus or not?

  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Antiphospholipid syndrome is a hypercoaguable state characterized by recurrent venous and/or arterial thrombosis and/or pregnancy complications of fetal loss, pre-eclampsia, or eclampsia in the presence of antiphospholipid antibodies. It was first described in the setting of systemic lupus erythematosus and subsequently recognized to also exist as an independent condition and in conjunction with a variety of other autoimmune, infectious, and malignant illnesses. These diseases have been called primary antiphospholipid syndrome and secondary antiphospholipid syndrome. However, the two conditions can have significant overlapping features. This paper reviews the similarities and the differences between the two conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Wilson WA, Gharavi AE, Koike T, et al.: International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999, 42:1309–1311.

    Article  PubMed  CAS  Google Scholar 

  2. Hochberg MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997, 40:1725.

    Article  PubMed  CAS  Google Scholar 

  3. Piette JC, Wechsler B, Francis C, Godeau P: Systemic lupus erythematosus and the antiphospholipid syndrome: reflections about the relevance of ARA criteria. J Rheumatol 1992, 19:1835–1837.

    PubMed  CAS  Google Scholar 

  4. Piette JC, Wechsler B, Frances C, et al.: Exclusion criteria for primary antiphospholipid syndrome. J Rheumatol 1993, 20:1802–1804.

    PubMed  CAS  Google Scholar 

  5. Alarcon-Segovia D, Sanchez-Guerrero J: Primary antiphospholipid syndrome. J Rheumatol 1989, 16:482–488.

    PubMed  CAS  Google Scholar 

  6. Asherson RA, Khamashta MA, Ordi-Ros J, et al.: The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989, 68:366–374.

    CAS  Google Scholar 

  7. Vianna JL, Khamashta MA, Ordi-Ros J, et al.: Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients. Am J Med 1994, 96:3–9. This is a early, large cohort that explores the similarities and differences in anitphopholipid syndrome.

    Article  PubMed  CAS  Google Scholar 

  8. Tan EM, Cohen AS, Fries JF, et al.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271–1277.

    Article  PubMed  CAS  Google Scholar 

  9. Weber M, Hayem G, de Bandt M, et al.: Classification of an intermediate group of patients with antiphospholipid syndrome and lupus-like disease: primary or secondary antiphospholipid syndrome? J Rheumatol 1999, 26:2131–2136. This study looks statistically at the differences between PAPS and SAPS using very strict criteria for PAPS. The intermediate group which is in general lupus-like, behaves more like the PAPS, and the authors conclude that it should be included in this group.

    PubMed  CAS  Google Scholar 

  10. Lockshin MD, Sammaritano LR, Schwartzman S: Validation of the Sapporo criteria for antiphospholipid syndrome. Arthritis Rheum 2000, 43:440–443.

    Article  PubMed  CAS  Google Scholar 

  11. Cervera R, Piette JC, Font J, et al.: Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002, 46:1019–1027. This is the largest cohort compiled to describe APS. It also is one of the few that uses the preliminary diagnostic criteria for APS.

    Article  PubMed  Google Scholar 

  12. Alarcon-Segovia D, Perez-Vazquez ME, Villa AR, et al.: Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Semin Arthritis Rheum 1992, 21:275–286.

    Article  PubMed  CAS  Google Scholar 

  13. Mujic F, Cuadrado MJ, Lloyd M, et al.: Primary antiphospholipid syndrome evolving into systemic lupus erythematosus. J Rheumatol 1995, 22:1589–1592.

    PubMed  CAS  Google Scholar 

  14. Andrews PA, Frampton G, Cameron JS: Antiphospholipid syndrome and systemic lupus erythematosus. Lancet 1993, 342:988–989.

    Article  PubMed  CAS  Google Scholar 

  15. Gomez JA, Martin H, Amigo MC, et al.: Long-term follow-up in 90 patients with primary antiphospholipid syndrome (PAPS). Do they develop lupus? Arthritis Rheum 2001, 44(Suppl):S146.

    Article  Google Scholar 

  16. Amigo MC, Gomez-Puera JA, Martin H, et al.: Long-term follow-up in 128 patients with primary APS(PAPS). Do they develop lupus? Lupus 2002, 11:552.

    Google Scholar 

  17. Gattorno M, Falcini F, Ravelli A, et al.: Outcome of primary antiphospholipid syndrome in childhood. Lupus 2003, 12:449–453.

    Article  PubMed  CAS  Google Scholar 

  18. Vargas-Alarcon G, Granados J, Bekker C, et al.: Association of HLA-DR5 (possibly DRB1*1201) with the primary antiphospholipid syndrome in Mexican patients. Arthritis Rheum 1995, 38:1340–1341.

    Article  PubMed  CAS  Google Scholar 

  19. Asherson RA, Doherty DG, Vergani D, et al.: Major histocompatibility complex associations with primary antiphospholipid syndrome. Arthritis Rheum 1992, 35:124–125.

    Article  PubMed  CAS  Google Scholar 

  20. Sebastiani GD, Galeazzi M, Morozzi G, Marcolongo R: The immunogenetics of the antiphospholipid syndrome, anticardiolipin antibodies, and lupus anticoagulant. Semin Arthritis Rheum 1996, 25:414–420.

    Article  PubMed  CAS  Google Scholar 

  21. Freitas MV, da Silva LM, Deghaide NH, et al.: Is HLA class II susceptibility to primary antiphospholipid syndrome different from susceptibility to secondary antiphospholipid syndrome? Lupus 2004, 13:125–131.

    Article  PubMed  CAS  Google Scholar 

  22. Karassa FB, Trikalinos TA, Ioannidis JP: Role of the Fcgamma receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis. Arthritis Rheum 2002, 46:1563–1571.

    Article  PubMed  CAS  Google Scholar 

  23. Karassa FB, Bijl M, Davies KA, et al.: Role of the Fcgamma receptor IIA polymorphism in the antiphospholipid syndrome: an international meta-analysis. Arthritis Rheum 2003, 48:1930–1938.

    Article  PubMed  CAS  Google Scholar 

  24. Moss KE, Isenberg DA: Comparison of renal disease severity and outcome in patients with primary antiphospholipid syndrome, antiphospholipid syndrome secondary to systemic lupus erythematosus (SLE) and SLE alone. Rheumatology (Oxford) 2001, 40:863–867. This is an interesting article that compares and contrasts the renal features of SLE, SLE with APS, and PAPS.

    Article  CAS  Google Scholar 

  25. Daugas E, Nochy D, Huong du LT, et al.: Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. J Am Soc Nephrol 2002, 13:42–52.

    Article  PubMed  Google Scholar 

  26. Khamashta MA, Cuadrado MJ, Mujic F, et al.: The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995, 332:993–997.

    Article  PubMed  CAS  Google Scholar 

  27. Crowther MA, Ginsberg JS, Julian J, et al.: A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med 2003, 349:1133–1138.

    Article  PubMed  CAS  Google Scholar 

  28. Amigo MC: Prognosis in antiphospholipid syndrome. Rheum Dis Clin North Am 2001, 27:661–669.

    Article  PubMed  CAS  Google Scholar 

  29. Ruiz-Irastorza G, Egurbide MV, Ugalde J, Aguirre C: High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus. Arch Intern Med 2004, 164:77–82.

    Article  PubMed  Google Scholar 

  30. Reshetnyak TM, Kalashnikova LA, Alexandrova EN, et al.: Outcome of 280 patients with systemic lupus erythemaotus and 74 patients with primary antiphospholipid syndrom: 8-year follow-up. J Autoimmun 2000, 15:A93.

    Google Scholar 

  31. Voisin L, Derumeaux G, Borg JY, et al.: Catastrophic antiphospholipid syndrome with fatal acute course in rheumatoid arthritis. J Rheumatol 1995, 22:1586–1588.

    PubMed  CAS  Google Scholar 

  32. Sherer Y, Livneh A, Levy Y, et al.: Dermatomyositis and polymyositis associated with the antiphospholipid syndrome-novel overlap syndrome. Lupus 2000, 9:42–46.

    Article  PubMed  CAS  Google Scholar 

  33. Vianna JL, D’Cruz DP, Khamashta MA, et al.: Anticardiolipin antibodies in a patient with Crohn’s disease and thrombosis. Clin Exp Rheumatol 1992, 10:165–168.

    PubMed  CAS  Google Scholar 

  34. Fauchais AL, Lambert M, Launay D, et al.: Antiphospholipid antibodies in primary Sjogren’s syndrome: prevalence and clinical significance in a series of 74 patients. Lupus 2004, 13:245–248.

    Article  PubMed  CAS  Google Scholar 

  35. Famularo G, Antonelli S, Barracchini A, et al.: Catastrophic antiphospholipid syndrome in a patient with Behcet’s disease. Scand J Rheumatol 2002, 31:100–102.

    Article  PubMed  Google Scholar 

  36. Minatani M, Takasaki J, Iwata H, et al.: Acute interstitial pneumonia associated with antiphospholipid syndrome in a patient with systemic sclerosis. Clin Exp Rheumatol 2000, 18:786.

    PubMed  CAS  Google Scholar 

  37. Ruffatti A, Montecucco C, Volante D, et al.: Antiphospholipid antibody syndrome and polymyalgia rheumatica/giant cell arteritis. Rheumatology (Oxford) 2000, 39:565–567.

    Article  CAS  Google Scholar 

  38. Ramos-Casals M, Cervera R, Lagrutta M, et al.: Clinical features related to antiphospholipid syndrome in patients with chronic viral infections (hepatitis C virus/HIV infection): description of 82 cases. Clin Infect Dis 2004, 38:1009–1016.

    Article  PubMed  Google Scholar 

  39. Asherson RA, Cervera R, Piette JC, et al.: Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore) 1998, 77:195–207.

    Article  CAS  Google Scholar 

  40. Genvresse I, Buttgereit F, Spath-Schwalbe E, et al.: Arterial thrombosis associated with anticardiolipin and anti-beta2-glycoprotein-I antibodies in patients with non-Hodgkin’s lymphoma: a report of two cases. Eur J Haematol 2000, 65:344–347.

    Article  PubMed  CAS  Google Scholar 

  41. El Rayes BF, Edelstein M: Unusual case of antiphospholipid antibody syndrome presenting with extensive cutaneous infarcts in a patient on long-term procainamide therapy. Am Hematol 2003, 72:154.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatology/ Department of Medicine, Geffen School of Medicine, UCLA, 1000 Veteran Ave. Room 32-59 UCLA, 90095, Los Angeles, CA, USA

    Jennifer M. Grossman MD

Authors
  1. Jennifer M. Grossman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grossman, J.M. Primary versus secondary antiphospholipid syndrome: Is this lupus or not?. Curr Rheumatol Rep 6, 445–450 (2004). https://doi.org/10.1007/s11926-004-0023-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-004-0023-2

Keywords

Search

Navigation